Wipro founder Azim Premji is an early investor in US firm Moderna
Wipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
Authors: Hamilton G PMID: 32441306 [PubMed - as supplied by publisher]
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
Publication date: Available online 22 May 2020Source: The LancetAuthor(s): Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, Shi-Po Wu, Bu-Sen Wang, Zhao Wang, Lei Wang, Si-Yue Jia, Hu-Dachuan Jiang, Ling Wang, Tao Jiang, Yi Hu, Jin-Bo Gou, Sha-Bei Xu, Jun-Jie Xu, Xue-Wen Wang, Wei Wang
The University of Oxford's COVID-19 vaccine trial has only a 50% chance of success as the coronavirus seems to be fading rapidly in Britain, the professor co-leading the development of the vaccine told the Telegraph newspaper https://bit.ly/2LQTNos.
Authors: Merante D PMID: 32442040 [PubMed - as supplied by publisher]
CONCLUSIONS AND CLINICAL RELEVANCE: A method was established in rabbits for evaluation of the efficacy of a CSFV subunit vaccine that could help in the optimization of later large-scale vaccine production and quality control processes as well as in the clinical application of the vaccine. PMID: 32436789 [PubMed - in process]
Thailand on Saturday began testing a vaccine against the coronavirus on monkeys after positive trials in mice, an official said.
Authors: Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, Abbott W, Mears E, Steele R, McKee J, Muscroft-Taylor A, Ameratunga S, Medlicott N, Das S, Rolleston W, Quiñones-Mateu M, Petousis-Harris H, Jordan A Abstract COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous health, economic and societal consequences. It causes disproportionately severe disease in the elderly and those with co-morbidities, such as hypertension and diabetes. There is currently no proven treatment ...
There's encouraging news from the two leading experimental coronavirus vaccine trials. Researchers in both trials have reported the presence of antibodies in volunteers after injecting them with experimental vaccines. Charlie D'Agata reports.
In the 1800s, smallpox ravaged the world. Fortunately, a vaccine had been developed that could protect individuals. This vaccine left a scar at the site of injection and identified the individuals as “immune.” As we look towards the future of the COVID-19 pandemic, unless the virus burns out or an effective therapeutic intervention becomes available, […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.